Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
The Journal of Rheumatology|March 9, 2007
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schemaMarissa N Lassere, Kent R Johnson, Maarten Boers, et al.The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validityPeter Tugwell, Maarten Boers, Maria-Antonietta D'Agostino, et al.Nature Reviews. Rheumatology|July 11, 2023
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforceKathryn Connelly, Laura E Eades, Rachel Koelmeyer, et al.The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: discrimination and feasibilityGeorge Wells, Dorcas E Beaton, Peter Tugwell, et al.Pain|December 9, 2003
Core outcome domains for chronic pain clinical trials: IMMPACT recommendationsDennis C Turk, Robert H Dworkin, Robert R Allen, et al.The Journal of Rheumatology|March 18, 2014
Updating the OMERACT filter: core areas as a basis for defining core outcome setsJohn R Kirwan, Maarten Boers, Sarah Hewlett, et al.International Journal of Molecular Sciences|September 20, 2014
A review of pinealectomy-induced melatonin-deficient animal models for the study of etiopathogenesis of adolescent idiopathic scoliosisGene Chi Wai Man, Man Gene Chi Wai, William Wei Jun Wang, et al.Seminars in Arthritis and Rheumatism|June 27, 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinementDorthe B Berthelsen, Ben Horgan, Lee Simon, et al.Pain|May 9, 2024
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statementDavid Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.Pageof 4